title: Predicting Blood Loss in Total Knee and Hip Arthroplasty.
abstract: Marked blood loss during lower extremity total joint arthroplasties may lead to higher rates of transfusion, which may negatively affect surgical outcomes and yield greater complication rates. It is therefore ideal to identify factors that may increase the likelihood of blood loss, so they can be modified. From this review, it can be concluded that preoperative anemia, older age, multiple comorbidities, increased operative time, and use of postoperative anticoagulation may lead to higher blood loss and transfusion rates, although the influence of other factors remains controversial.
authors.affiliation: Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MA 21215, USA.
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Sizer
authors.affiliation: Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MA 21215, USA.
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Cherian
authors.affiliation: Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MA 21215, USA.
authors.forename: Randa D K
authors.initials: RD
authors.lastname: Elmallah
authors.affiliation: Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MA 21215, USA.
authors.forename: Todd P
authors.initials: TP
authors.lastname: Pierce
authors.affiliation: OrthoCarolina Hip and Knee Center, 2001 Vail Avenue, Charlotte, NC 28207, USA.
authors.forename: Walter B
authors.initials: WB
authors.lastname: Beaver
authors.affiliation: Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MA 21215, USA. Electronic address: mmont@lifebridgehealth.org.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Mont
mesh_terms: D000740:Anemia / Q000175:diagnosis / Q000628:therapy; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D019645:Arthroplasty, Replacement, Knee; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D006305:Health Status Indicators; D006801:Humans; D019106:Postoperative Hemorrhage; D011237:Predictive Value of Tests; D012307:Risk Factors; D014148:Tranexamic Acid / Q000627:therapeutic use
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid
keywords: Blood loss; Total hip arthroplasty; Total knee arthroplasty; Tranexamic acid; Transfusion risk